Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Sollers attracted a soft loan of ₽3.4 billion

1/15/24 SVAV

Hard discounter chain B1 plans to accelerate the pace of expansion

1/15/24 MGNT

Mosgorlombard's loan portfolio grew by 71% in 2023

1/15/24 MGKL

Novabev Group's shipments for 2023 increased by 1%

1/15/24 BELU

Kairat Itemgenov bought 26.19% of Globaltrans

1/15/24 GLTR

Lukoil's Nizhny Novgorod refinery shut down a catalytic cracking unit

1/15/24 LKOH

Yandex.Lavka launches a franchise of darkstores

1/15/24 YNDX

Cosmos Hotel Group will build a five-star hotel on the Caspian Sea shore

1/15/24 AFKS

Detsky Mir shareholders will discuss the company's liquidation on February 14

1/12/24 DSKY

Detsky Mir's board of directors will discuss the company's liquidation

1/12/24 DSKY